Quotes 5-day view End-of-day quote Shanghai Stock Exchange
01/31/2023
02/01/2023
02/02/2023
02/03/2023
02/06/2023
Date
42.21
42.64
43
42.8
42.49
Last
40917550
39641360
65348650
49801810
37917260
Volume
-2.40%
+1.02%
+0.84%
-0.47%
-0.72%
Change
Estimated financial data (e) CNY USD
Sales 2022
22 356 M
3 292 M
3 292 M
Net income 2022
4 247 M
625 M
625 M
Net cash position 2022
18 746 M
2 760 M
2 760 M
P/E ratio 2022
63,5x
Yield 2022
0,30%
Sales 2023
25 477 M
3 751 M
3 751 M
Net income 2023
4 955 M
730 M
730 M
Net cash position 2023
21 352 M
3 144 M
3 144 M
P/E ratio 2023
54,6x
Yield 2023
0,34%
Capitalization
271 B
40 074 M
39 901 M
EV / Sales 2022
11,3x
EV / Sales 2023
9,80x
Nbr of Employees
24 491
Free-Float
48,4%
Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products:
- anti-tumor drugs (No. 1 Chinese);
- Anesthetic drugs;
- contrast agents: used in medical imaging;
- anti-inflammatory drugs;
- drugs for the treatment of cardiovascular diseases.
Ratings of Jiangsu Hengrui Medicine Co., Ltd.
All news about JIANGSU HENGRUI MEDICINE CO., LTD.
News in other languages on JIANGSU HENGRUI MEDICINE CO., LTD.
Analyst Recommendations on JIANGSU HENGRUI MEDICINE CO., LTD.
ETFs positioned on JIANGSU HENGRUI MEDICINE CO., LTD. ETFs and Trackers with Trackinsight
Chart JIANGSU HENGRUI MEDICINE CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends JIANGSU HENGRUI MEDICINE CO., LTD.
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
21
Last Close Price
42,49 CNY
Average target price
50,89 CNY
Spread / Average Target
19,8%
Please enable JavaScript in your browser's settings to use dynamic charts.